Pulse Biosciences (PLSE) Stock: Why It's Up Today
Updated Oct 20, 2026, 4:00 PM ET Β· closing price
- Closed at $50.84, +6.92% vs the prior close of $47.55.
- Volume 385.90K shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Medline (MDLN)Becton Dickinson (BDX)
PLSE jumps 6.9% to $50.84. Closed at $50.84, +6.92% vs the prior close of $47.55. Day range $47.25β$52.33, opened at $47.25.
PLSE daily analysis β what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 20, 2026 β PLSE jumps 6.9% to $50.84
- Closed at $50.84, +6.92% vs the prior close of $47.55. Day range $47.25β$52.33, opened at $47.25.
- Volume was 385.90K shares, 0.7x its 50-day average of 540.37K.
- Price is +1.9% vs its 50-day average ($49.89) and +70.5% vs its 200-day average ($29.81).
- 52-week range $12.56β$58.90; today's close sits at 83% of that range, 13.7% below the 52-week high.
Oct 19, 2026 β PLSE jumps 7.0% to $47.55
- Closed at $47.55, +7.02% vs the prior close of $44.43. Day range $44.58β$48.12, opened at $44.58.
- Volume was 342.45K shares, 0.6x its 50-day average of 548.21K.
- Price is -4.3% vs its 50-day average ($49.71) and +60.5% vs its 200-day average ($29.62).
- 52-week range $12.56β$58.90; today's close sits at 76% of that range, 19.3% below the 52-week high.
Oct 16, 2026 β PLSE dips 2.5% to $44.43, a 1-month low, 5 down days in a row
- Closed at $44.43, -2.54% vs the prior close of $45.59. Day range $43.32β$46.67, opened at $45.49.
- Volume was 327.40K shares, 0.6x its 50-day average of 547.01K β lighter than usual.
- Price is -10.4% vs its 50-day average ($49.60) and +50.8% vs its 200-day average ($29.45).
- 52-week range $12.56β$58.90; today's close sits at 69% of that range, 24.6% below the 52-week high.
- That makes 5 straight losses.
Oct 15, 2026 β PLSE dips 1.6% to $45.59, a 1-month low, 4 down days in a row
- Closed at $45.59, -1.58% vs the prior close of $46.32. Day range $43.96β$46.67, opened at $45.13.
- Volume was 425.60K shares, 0.8x its 50-day average of 543.00K.
- Price is -7.9% vs its 50-day average ($49.48) and +55.6% vs its 200-day average ($29.30).
- 52-week range $12.56β$58.90; today's close sits at 71% of that range, 22.6% below the 52-week high.
- That makes 4 straight losses.
Oct 14, 2026 β PLSE slides 4.6% to $46.32, a 1-month low, 3 down days in a row
- Closed at $46.32, -4.57% vs the prior close of $48.54. Day range $44.80β$48.97, opened at $47.60.
- Volume was 440.30K shares, 0.8x its 50-day average of 541.05K.
- Price is -6.1% vs its 50-day average ($49.33) and +58.9% vs its 200-day average ($29.14).
- 52-week range $12.56β$58.90; today's close sits at 73% of that range, 21.4% below the 52-week high.
- That makes 3 straight losses.
- SEC filings that day: 8-K.
Oct 13, 2026 β PLSE slides 7.5% to $48.54
- Closed at $48.54, -7.45% vs the prior close of $52.45. Day range $48.01β$53.21, opened at $53.02.
- Volume was 455.50K shares, 0.8x its 50-day average of 538.98K.
- Price is -1.3% vs its 50-day average ($49.16) and +67.5% vs its 200-day average ($28.98).
- 52-week range $12.56β$58.90; today's close sits at 78% of that range, 17.6% below the 52-week high.
Oct 12, 2026 β PLSE dips 2.5% to $52.45
- Closed at $52.45, -2.53% vs the prior close of $53.81. Day range $50.15β$53.98, opened at $53.53.
- Volume was 434.40K shares, 0.8x its 50-day average of 535.85K.
- Price is +7.2% vs its 50-day average ($48.95) and +82.0% vs its 200-day average ($28.82).
- 52-week range $12.56β$58.90; today's close sits at 86% of that range, 11.0% below the 52-week high.
Oct 9, 2026 β PLSE jumps 7.7% to $53.81
- Closed at $53.81, +7.66% vs the prior close of $49.98. Day range $49.98β$53.97, opened at $49.98.
- Volume was 365.80K shares, 0.7x its 50-day average of 535.01K.
- Price is +10.7% vs its 50-day average ($48.60) and +88.0% vs its 200-day average ($28.63).
- 52-week range $12.56β$58.90; today's close sits at 89% of that range, 8.6% below the 52-week high.
Oct 8, 2026 β PLSE rises 1.8% to $49.98
- Closed at $49.98, +1.81% vs the prior close of $49.09. Day range $47.31β$50.32, opened at $48.90.
- Volume was 315.60K shares, 0.6x its 50-day average of 547.22K β lighter than usual.
- Price is +3.6% vs its 50-day average ($48.22) and +75.8% vs its 200-day average ($28.43).
- 52-week range $12.56β$58.90; today's close sits at 81% of that range, 15.1% below the 52-week high.
Oct 7, 2026 β PLSE dips 1.3% to $49.09
- Closed at $49.09, -1.33% vs the prior close of $49.75. Day range $48.13β$49.93, opened at $49.11.
- Volume was 409.50K shares, 0.7x its 50-day average of 552.70K.
- Price is +2.5% vs its 50-day average ($47.91) and +73.7% vs its 200-day average ($28.26).
- 52-week range $12.56β$58.90; today's close sits at 79% of that range, 16.7% below the 52-week high.
- SEC filings that day: 8-K.
Oct 6, 2026 β PLSE dips 1.5% to $49.75
- Closed at $49.75, -1.49% vs the prior close of $50.50. Day range $48.62β$51.26, opened at $51.26.
- Volume was 421.40K shares, 0.8x its 50-day average of 552.92K.
- Price is +4.4% vs its 50-day average ($47.64) and +77.1% vs its 200-day average ($28.09).
- 52-week range $12.56β$58.90; today's close sits at 80% of that range, 15.5% below the 52-week high.
Oct 5, 2026 β PLSE jumps 5.4% to $50.50
- Closed at $50.50, +5.43% vs the prior close of $47.90. Day range $47.47β$50.99, opened at $47.89.
- Volume was 433.40K shares, 0.8x its 50-day average of 551.60K.
- Price is +6.8% vs its 50-day average ($47.30) and +80.9% vs its 200-day average ($27.91).
- 52-week range $12.56β$58.90; today's close sits at 82% of that range, 14.3% below the 52-week high.
Oct 2, 2026 β PLSE slides 3.9% to $47.90, a 1-month low, 4 down days in a row
- Closed at $47.90, -3.87% vs the prior close of $49.83. Day range $47.75β$50.71, opened at $50.13.
- Volume was 519.10K shares, 0.9x its 50-day average of 551.08K.
- Price is +2.1% vs its 50-day average ($46.89) and +72.8% vs its 200-day average ($27.73).
- 52-week range $12.56β$58.90; today's close sits at 76% of that range, 18.7% below the 52-week high.
- That makes 4 straight losses.
PLSE bull case vs bear case (from the data)
- Price is +1.9% vs its 50-day average β short-term trend is up.
- Price is +70.5% vs its 200-day average β above the long-term trend line.
- Insiders made 25 open-market purchases in the last 12 months.
- Latest fiscal-year net income: loss of $72.78M.
- Share count up 6.0% in a year (dilution).
- High volatility: average daily move of 3.1% over 20 sessions.
PLSE latest news & SEC filings
Every SEC filing by or about PLSE in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 8.01 β Reported other events the company considers important.
Oct 7, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 8.01 β Reported other events the company considers important.
Sep 15, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 1.01 β Signed a material agreement.
- Item 1.02 β Ended a material agreement.
Sep 15, 2026 Β· Form 424B5 β Prospectus supplement
Prospectus supplement β the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 15, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 8.01 β Reported other events the company considers important.
Sep 2, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Teplitsky Liane Rae bought 1,001 shares at $49.95 (β$50.00K) on Sep 1, 2026
- Teplitsky Liane Rae bought 1,001 shares at $49.95 (β$50.00K) on Sep 1, 2026
- Teplitsky Liane Rae bought 1,001 shares at $49.95 (β$50.00K) on Sep 1, 2026
- Teplitsky Liane Rae bought 1,001 shares at $49.95 (β$50.00K) on Sep 1, 2026
- Teplitsky Liane Rae bought 1,024 shares at $48.80 (β$49.97K) on Aug 31, 2026
- Teplitsky Liane Rae bought 1,024 shares at $48.80 (β$49.97K) on Aug 31, 2026
- β¦plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 28, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Teplitsky Liane Rae bought 1,034 shares at $48.35 (β$49.99K) on Aug 28, 2026
- Teplitsky Liane Rae bought 1,034 shares at $48.35 (β$49.99K) on Aug 28, 2026
- Teplitsky Liane Rae bought 1,034 shares at $48.35 (β$49.99K) on Aug 28, 2026
- Teplitsky Liane Rae bought 1,034 shares at $48.35 (β$49.99K) on Aug 28, 2026
- Teplitsky Liane Rae bought 1,036 shares at $48.24 (β$49.98K) on Aug 26, 2026
- Teplitsky Liane Rae bought 1,036 shares at $48.24 (β$49.98K) on Aug 26, 2026
- β¦plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 28, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 28, 2026 Β· Form 3 β New insider holdings
Initial insider ownership statement (Form 3) β a new director, officer or 10% owner disclosed their holdings
Aug 28, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 28, 2026 Β· Form 3 β New insider holdings
Initial insider ownership statement (Form 3) β a new director, officer or 10% owner disclosed their holdings
Aug 6, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 1.01 β Signed a material agreement.
Aug 6, 2026 Β· Form 424B5 β Prospectus supplement
Prospectus supplement β the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 6, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $434.00K (prior year $0)
- Net income: -$24.66M (prior year -$19.17M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.36 (prior year -$0.28) (loss widened vs Jun 30, 2025)
Aug 6, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.02 β Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade PLSE
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 4, 2026, Feb 19, 2026, Nov 5, 2025. Based on that rhythm, the next report is likely around Nov 5, 2026 β an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.12% (largest 7.7%). That is a volatile stock.
- Liquidity: about 455.20K shares (β$23.14M) trade per day on average.
- 52-week position: $50.84 vs a range of $12.56β$58.90 (83% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Liane Rae Teplitsky bought 1,001 shares on Sep 1, 2026.
- Latest filings: 8-K Oct 14, 2026; 8-K Oct 7, 2026; 8-K Sep 15, 2026.
- Share count: 71.32M shares outstanding (Jul 31, 2026), +6.0% vs a year earlier β notable dilution.
- Listing: Nasdaq Β· industry: Surgical & Medical Instruments & Apparatus.
PLSE market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 20, 2026 | 47.25 | 52.33 | 47.25 | 50.84 | 385.90K |
| Oct 19, 2026 | 44.58 | 48.12 | 44.58 | 47.55 | 342.50K |
| Oct 16, 2026 | 45.49 | 46.67 | 43.32 | 44.43 | 327.40K |
| Oct 15, 2026 | 45.13 | 46.67 | 43.96 | 45.59 | 425.60K |
| Oct 14, 2026 | 47.60 | 48.97 | 44.80 | 46.32 | 440.30K |
| Oct 13, 2026 | 53.02 | 53.21 | 48.01 | 48.54 | 455.50K |
| Oct 12, 2026 | 53.53 | 53.98 | 50.15 | 52.45 | 434.40K |
| Oct 9, 2026 | 49.98 | 53.97 | 49.98 | 53.81 | 365.80K |
| Oct 8, 2026 | 48.90 | 50.32 | 47.31 | 49.98 | 315.60K |
| Oct 7, 2026 | 49.11 | 49.93 | 48.13 | 49.09 | 409.50K |
| Oct 6, 2026 | 51.26 | 51.26 | 48.62 | 49.75 | 421.40K |
| Oct 5, 2026 | 47.89 | 50.99 | 47.47 | 50.50 | 433.40K |
| Oct 2, 2026 | 50.13 | 50.71 | 47.75 | 47.90 | 519.10K |
| Oct 1, 2026 | 49.49 | 51.56 | 49.12 | 49.83 | 450.30K |
| Sep 30, 2026 | 51.18 | 51.27 | 49.17 | 49.92 | 604.60K |
| Sep 29, 2026 | 52.24 | 52.74 | 48.92 | 50.89 | 516.90K |
| Sep 28, 2026 | 51.63 | 53.60 | 51.14 | 52.32 | 374.40K |
| Sep 25, 2026 | 52.17 | 54.05 | 50.80 | 51.63 | 664.00K |
| Sep 24, 2026 | 52.18 | 53.60 | 51.62 | 51.83 | 666.90K |
| Sep 23, 2026 | 53.75 | 56.74 | 51.87 | 51.98 | 550.60K |
About Pulse Biosciences
Pulse Biosciences (PLSE) is listed on the Nasdaq and classified by the SEC under βSurgical & Medical Instruments & Apparatusβ. Its business address is in HAYWARD, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1625101.
PLSE board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Robert W Duggan | Director | Jun 15, 2026 |
| Paul A Laviolette | Chief Executive Officer | May 11, 2026 |
| Maria Sainz | Director | Jun 15, 2026 |
| Manmeet Singh Soni | Director | Jun 15, 2026 |
| Darrin Uecker | Chief Technology Officer | Apr 3, 2026 |
| Mahkam Zanganeh | Director | Jun 15, 2026 |
| Den Broek Richard Van | Director | Jun 15, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Kevin Patrick Danahy | Chief Commercial Officer | Feb 23, 2026 |
| Paul A Laviolette | Chief Executive Officer | May 11, 2026 |
| Jon Skinner | Chief Financial Officer | Aug 28, 2026 |
| Liane Rae Teplitsky | Chief Operating Officer | Sep 2, 2026 |
| Darrin Uecker | Chief Technology Officer | Apr 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 1, 2026 | Liane Rae Teplitsky | Buy | 1,001 | $49.95 |
| Sep 1, 2026 | Liane Rae Teplitsky | Buy | 1,001 | $49.95 |
| Sep 1, 2026 | Liane Rae Teplitsky | Buy | 1,001 | $49.95 |
| Sep 1, 2026 | Liane Rae Teplitsky | Buy | 1,001 | $49.95 |
| Aug 31, 2026 | Liane Rae Teplitsky | Buy | 1,024 | $48.80 |
| Aug 31, 2026 | Liane Rae Teplitsky | Buy | 1,024 | $48.80 |
| Aug 31, 2026 | Liane Rae Teplitsky | Buy | 1,024 | $48.80 |
| Aug 31, 2026 | Liane Rae Teplitsky | Buy | 1,024 | $48.80 |
| Aug 28, 2026 | Liane Rae Teplitsky | Buy | 1,034 | $48.35 |
| Aug 28, 2026 | Liane Rae Teplitsky | Buy | 1,034 | $48.35 |
| Aug 28, 2026 | Liane Rae Teplitsky | Buy | 1,034 | $48.35 |
| Aug 28, 2026 | Liane Rae Teplitsky | Buy | 1,034 | $48.35 |
| Aug 26, 2026 | Liane Rae Teplitsky | Buy | 1,036 | $48.24 |
| Aug 26, 2026 | Liane Rae Teplitsky | Buy | 1,036 | $48.24 |
| Aug 26, 2026 | Liane Rae Teplitsky | Buy | 1,036 | $48.24 |
PLSE financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $350.00K | $-72.78M | -1.08 | $-54.12M |
| Dec 31, 2024 | $0 | $-53.59M | -0.92 | $-36.34M |
| Dec 31, 2023 | $0 | $-42.21M | -0.85 | $-33.04M |
| Dec 31, 2022 | $700.00K | $-58.51M | -1.72 | $-47.01M |
| Dec 31, 2021 | $1.42M | $-63.66M | -2.28 | $-54.10M |
Latest balance sheet: total assets $115.56M, total liabilities $16.06M, cash $101.62M (as of Jun 30, 2026).
PLSE earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $38.24 |
| May 4, 2026 | 8-K Item 2.02 (results) | $20.03 |
| Feb 19, 2026 | 8-K Item 2.02 (results) | $25.08 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $16.27 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $15.10 |
| May 8, 2025 | 8-K Item 2.02 (results) | $16.85 |
| Mar 28, 2025 | 8-K Item 2.02 (results) | $16.60 |
| Oct 30, 2024 | 8-K Item 2.02 (results) | $17.72 |
| Aug 12, 2024 | 8-K Item 2.02 (results) | β |
| Jul 15, 2024 | 8-K Item 2.02 (results) | β |
| May 7, 2024 | 8-K Item 2.02 (results) | β |
| Mar 28, 2024 | 8-K Item 2.02 (results) | β |
Related stocks Β· Surgical & Medical Instruments & Apparatus
Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Medline (MDLN)Becton Dickinson (BDX)Dexcom (DXCM)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Space Exploration Technologies (SPCX)Tesla (TSLA)Sandisk (SNDK)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on PLSE
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 20, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.